Pfizer Vaccine Effective Against South African Variant

The video discusses a drugmaker's phase three clinical trial involving 12,000 participants, which showed high levels of protection against COVID-19, including the South African variant, six months after the second dose. The company plans to seek full FDA approval and has submitted trial data for peer review.

What variant of COVID-19 was the vaccine reported to be effective against?

How many participants were involved in the phase three clinical trial?

What was the duration after which participants developed high levels of protection?

What action did Fraser say the drugmaker would take regarding FDA approval?

What did the drugmaker submit for peer review?